Swan EndoSurgical Appoints Former Stryker Robotics Leader Erik Todd as Chief Executive Officer

Swan EndoSurgical, an emerging leader in flexible endoluminal surgical robotics, announced the appointment of Erik Todd as its Chief Executive Officer. Erik joins Swan following more than 25 years of leadership at Stryker Corporation, where he most recently served as Vice President and General Manager of the Robotics and Enabling Technologies division.

Erik brings deep experience scaling next-generation robotic platforms, building high-performance global engineering organizations, and driving innovation across endoscopy, minimally invasive surgery, and digital/AI-enabled enabling technologies.

Swan EndoSurgical is backed by Revival Healthcare Capital and Olympus Corporation and is focused on delivering a fully integrated flexible endoluminal robotic platform for complex gastrointestinal interventions.

“Erik is an accomplished and respected leader in surgical robotics,” said Justin Ballotta, Managing Director at Revival Healthcare Capital and Head of Post-Investment Value Creation. “With a proven track record of scaling sophisticated robotics platforms from concept through commercialization, Erik brings a global perspective, strategic rigor, and a deep appreciation for clinical needs making him the ideal leader for Swan.”

“The appointment of Erik to Swan EndoSurgical as the CEO marks a pivotal step in advancing our shared vision for endoluminal robotics,” said Bob White, Representative Executive Officer, President and Chief Executive Officer at Olympus Corporation. “Together, we are committed to transforming gastrointestinal care through breakthrough robotics, empowering physicians, and delivering safer, less invasive solutions for patients everywhere.”

Erik Todd, Chief Executive Officer, said, “I am excited to join Swan EndoSurgical and help advance endoluminal surgery. Building on the foundation created by Swan, Revival, and Olympus, we can address unmet needs in advanced GI interventions using robotics, visualization, and flexible access. I look forward to collaborating with Olympus, health care professionals, and our teams to develop, deliver, and scale meaningful innovations for patients around the world.”